Keywords
arylidene indolones
enzyme docking
indolones
sulfonamides
α-glucosidase inhibitor
Abstract
3-Arylidene-1-(2,6-dichlorophenyl)indolones and in particular their 5-methylaminosulfonyl derivatives efficiently inhibit α-glucosidase enzyme. The results are corroborated by in silico docking studies which show the binding of aminosulfonyl derivatives to be more favorable due to additional hydrogen bonding. The most active compound of the series shows the IC50 of 6.19 μm.
References
1.
Dolomanov O.V., Bourhis L.J., Gildea R.J., Howard J.A., Puschmann H.
Journal of Applied Crystallography,
2009
2.
Sheldrick G.M.
Acta Crystallographica Section A: Foundations and Advances,
2015
3.
Indole in the target-based design of anticancer agents: A versatile scaffold with diverse mechanisms
Dadashpour S., Emami S.
European Journal of Medicinal Chemistry,
2018
4.
Isik S., Kockar F., Aydin M., Arslan O., Guler O.O., Innocenti A., Scozzafava A., Supuran C.T.
Bioorganic and Medicinal Chemistry,
2009
5.
Zhang M., Chen Q., Yang G.
European Journal of Medicinal Chemistry,
2015
6.
Elgemeie G.H., Azzam R.A., Elsayed R.E.
Medicinal Chemistry Research,
2019
7.
Khetmalis Y.M., Shivani M., Murugesan S., Chandra Sekhar K.V.
Biomedicine and Pharmacotherapy,
2021
8.
Khan M., Yousaf M., Wadood A., Junaid M., Ashraf M., Alam U., Ali M., Arshad M., Hussain Z., Khan K.M.
Bioorganic and Medicinal Chemistry,
2014
9.
Yamamoto K., Miyake H., Kusunoki M., Osaki S.
FEBS Journal,
2010
10.
11.
Chu W., Rothfuss J., d'Avignon A., Zeng C., Zhou D., Hotchkiss R.S., Mach R.H.
Journal of Medicinal Chemistry,
2007
12.
Homer J.A., Sperry J.
Journal of Natural Products,
2017
13.
Manvar A., Bavishi A., Loriya R., Jaggi M., Shah A.
Medicinal Chemistry Research,
2012
14.
Wei C., Yang X., Shi S., Bai L., Hu D., Song R., Song B.
Journal of Agricultural and Food Chemistry,
2022
15.
Azevedo-Barbosa H., Dias D.F., Franco L.L., Hawkes J.A., Carvalho D.T.
Mini-Reviews in Medicinal Chemistry,
2020
16.
Riaz S., Khan I.U., Bajda M., Ashraf M., Qurat-ul-Ain, Shaukat A., Rehman T.U., Mutahir S., Hussain S., Mustafa G., Yar M.
Bioorganic Chemistry,
2015
17.
Sun H., Zhang Y., Ding W., Zhao X., Song X., Wang D., Li Y., Han K., Yang Y., Ma Y., Wang R., Wang D., Yu P.
European Journal of Medicinal Chemistry,
2016
18.
Taha M., Imran S., Rahim F., Wadood A., Khan K.M.
Bioorganic Chemistry,
2018
19.
Azevedo-Barbosa H., Ferreira-Silva G.Á., Silva C.F., de Souza T.B., Dias D.F., de Paula A.C., Ionta M., Carvalho D.T.
Toxicology in Vitro,
2019
20.
Galieva N.A., Saveliev D.A., Eltsov O.S., Bakulev V.A., Lubec G., Xing J., Fan Z., Beryozkina T.V.
Mendeleev Communications,
2021
21.
El-sayed M.T., Hamdy N.A., Osman D.A., Ahmed K.M.
Advances in modern oncology research,
2015
22.
Kaur J., Utreja D., Ekta, Jain N., Sharma S.
Current Organic Synthesis,
2018
23.
Wang J., Lu S., Sheng R., Fan J., Wu W., Guo R.
Mini-Reviews in Medicinal Chemistry,
2020
24.
Saini T., Kumar S., Narasimhan B.
Central Nervous System Agents in Medicinal Chemistry,
2015